Abstract
Background and purpose
Conditioned pain modulation (CPM) is a testing paradigm representing features of diffuse noxious inhibitory control. There is large diversity in the paradigms applied to induce CPM, and the consistency in CPM responses assessed by different paradigms is largely unknown. We aimed to characterize and explore the associations between the CPM responses assessed by different paradigms in the same cohort.
Methods
Thirty-three healthy middle-aged subjects underwent six CPM paradigms. The ‘test-stimuli’, consisted of thermal and mechanical modalities, using pain thresholds, suprathreshold pain and temporal summation types of measurements. The ‘conditioning-stimulus’ consisted of a contact heat stimulus applied to the thener of the left hand for 60s at an intensity of 46.5°C.
Results
Large variability was observed among the responses to the different CPM paradigms. Surprisingly, no correlations were found between the various CPM responses.
Conclusions
The variability in the CPM responses may suggest that the capacity of pain modulation is a multifaceted trait, whose expression varies with the application of different CPM paradigms.
Implications
Considering that CPM responses may represent different processes when assessed by different paradigms, we encourage the use of more than one CPM paradigm.
1 Introduction
Pain modulation processes have been recognized as a key factor in depicting the characteristics of the individual pain profile. One of the most explored mechanisms underlying the pain modulation system is the ‘diffuse noxious inhibitory control’ (DNIC), which is mediated by activation of the spino-bulbo-spinal loop[1]. The DNIC phenomenon is manifested as a decrease in pain sensation evoked by a ‘test-stimulus’ during or following the application of another noxious stimulus, termed the ‘conditioning-stimulus’. This ‘pain inhibits pain’ phenomenon can be measured psychophysically in humans by the conditioned pain modulation (CPM) paradigm [2]. Less efficient DNIC was reported in various populations of idiopathic pain disorders, such as tempomandibular disorder [3,4,5,6]; irritable bowel syndrome[3,7,8];fibromyalgia[9,10,11,12,13]; and tension-type headache [14]. Furthermore, less efficient DNIC was found to be associated with a higher self-report of pain history among healthy subjects [15]. Less efficient CPM was also found to predict the development of chronic post-surgical pain [16,17] and high response to some analgesics [18]. These findings further support the role of prospective assessment of CPM as a valuable laboratory test supporting assessment.
Along with the growing interest in the potential clinical relevance of CPM, a large variability in thenar eminence the techniques applied to induce the CPM response can be found (see a review by Pud et al. [19]); numerous types of ‘test’ and ‘conditioning’ stimuli are used to evoke CPM, with different psychophysical measures (pain threshold, pain scores of supra-threshold stimulus, pain tolerance, or temporal summation), various stimulation modalities (thermal, mechanical, electrical, or ischemic), and different body sites. Moreover, a large variability is found in the CPM extents [19], probably due to the use of different paradigms in the different laboratories. This study was conducted to address the question of consistency of individuals’ expression of their pain modulation when induced by a variety of test protocols. We, therefore, aimed to characterize the results of CPM responses evoked by different paradigms in one cohort.
2 Methods
2.1 Subjects
Participants were 33 healthy subjects (18 women and 15 men), meanage 52.4±7.5.They were recruited by advertisement and met the following inclusion criteria: (1) absence of chronic pain history; (2) no use of analgesic or psychiatric medication on a regular basis; (3) ability to communicate and understand the instructions of the study; and (4) age above 40. Subjects were asked to refrain from pain relief medications in the 24h prior to the experimental trial.
2.2 Study design
The study was approved by the local Ethics Committee, and informed consent was obtained from all of subjects prior to the first experiment. The present study was part of a bigger research project involving ten CPM paradigms conducted in four sessions, each lasted approximately 1h. The sessions were separated by at least three days. Here we present the analyses obtained from six different ‘test-stimuli’ used in parallel to a single ‘conditioning-stimulus’, The CPM paradigms were performed in random order by three examiners (H.N.-A., E.G., and P.D.), who were blind to the CPM results measured by the other examiners, Subjects completed the personality questionnaires in the first session.
Fifteen minutes after the initial administration of the ‘test-stimulus’, the ‘conditioning-stimulus’ was delivered by contact heat, which was applied to the non-dominant the nar eminence for 60s at an intensity of 46.5°C. Subjects were asked to verbally rate their pain intensity, using a 0–100 Numerical Pain Scale (NPS), three times during the first 30 s of the stimulus (at 10, 20, and 30s). The final pain score was calculated by averaging these three pain ratings. In parallel to the last 30s of the ‘conditioning-stimulus’, the ‘test-stimulus’ was repeated. The CPM response was calculated as the difference between the pain scores of the two ‘test-stimuli’ (during the ‘conditioning-stimulus’ minus before it). A negative value for CPM response represents pain reduction with a more efficient CPM response. Each paradigm was termed according to the chosen ‘test-stimulus’. The six CPM paradigms are presented in Table 1.
Characteristics of the various CPM protocols.
CPM protocol | ‘Test-stimulus’ | ‘Conditioning-stimulus’ |
---|---|---|
HPT | Heat pain threshold | Contact heat |
PPT | Pressure pain threshold | Contact heat |
HP | Heat pain | Contact heat |
PP | Pressure pain | Contact heat |
tTS | Thermal temporal summation | Contact heat |
mTS | Mechanical temporal summation | Contact heat |
2.3 Characteristics of the various ‘test-stimuli’
2.3.1 Heat pain threshold (HPT)
Two contact heat stimuli were delivered to the dominant volar forearm, using the Thermal Sensory Analyzer (TSA) 2001 system (Medoc, Ramat Yishay, Israel), with a 30×30mm Peltier surface stimulator. The rate of temperature increase was 1.5°C/s, and the rate of its return to baseline (32°C) was 10.0°C/s. Subjects were instructed to identify the point when the stimulus was first perceived as painful by pressing the ‘stop’ button on the response unit. Heat pain threshold (HPT) was calculated by averaging the threshold temperatures (°C) of two successive trials.
2.3.2 Pressure pain threshold (PPT)
Mechanical pressure stimulus of increasing intensity was applied to the forearm using a pressure algometer (Somedic, Sweden) with a probe diameter of 1cm. The subjects were instructed to press the ‘stop’ button at the point when the stimulus was first perceived as painful. The pressure pain threshold (PPT) was calculated by averaging the threshold pressure (kPa) of four successive trials.
2.3.3 Heat pain (HP)
Tonic heat pain (HP) stimulation was applied to the dominant volar forearm, using TSA with a 30 × 30 mm Peltier surface stimulator. The stimuli were administered at the intensity of pain60, which is the temperature that induces pain scoring at a magnitude of 60 on a 0–100 NPS. The pain60 temperature was determined individually in the dominant volar forearm before application of the HP stimulation (for more details, see Granot et al. [20]). The ‘test-stimulus’ was delivered 10 min after determining the pain60 temperature. The rate of increasing and decreasing the temperature from the baseline was 2 °C/s. The stimulation was applied for 30 s, during which subjects were asked to verbally rate their pain intensity on an NPS at 10, 20, and 30 s. The final ‘test-stimulus’ pain score was determined by averaging these three pain ratings.
2.3.4 Pressure pain (PP)
Pressure pain (PP) stimulation was applied to the volar forearm, using a pressure algometer (Somedic, Sweden). Stimuli were administered at the pain60 intensity, which is the kPa value that induces pain scoring at a magnitude of 60 on a 0–100 NPS in the dominant volar forearm. The ‘test-stimulus’ was delivered 10 min after individually determining the pain60 intensity. Subjects were asked to verbally rate their pain intensity on an NPS at the peak of this phasic stimulus. The final pain scores were determined by averaging the results of two trials.
2.3.5 Mechanical temporal summation (mTS)
In order to evoke mechanical temporal summation (mTS), a train of 10 identical pinprick stimuli was delivered to the dominant volar forearm, using Von Frey monofilaments (Stoelting, Wood Dale, IL) of 6.45 Nm (225.1 g). The stimuli were administered at an interstimulus interval (ISI) of 2 Hz within an area of 1 cm2. The subjects were asked to verbally rate their pain intensity on an NPS for the first pinprick stimulus and then for the last stimulus in the series often. The mTS value was calculated as the difference between the pain scorings obtained for the last and the first pinprick stimuli (last minus first).
2.3.6 Thermal temporal summation (tTS)
In order to induce thermal temporal summation (tTS), a series of 10 brief repetitive supra-threshold thermal stimuli was applied to the thenar eminence of the dominant hand, using the Pathway (Pain & Sensory Evaluation System, Medoc, Israel), with a 27 mm diameter round probe. Stimuli were administered at the pain60 intensity, with an inter stimulus interval (onset-to-onset) of 2.5 s and a plateau duration of 0.7 s. The adaptation temperature was 39°C, the increase rate was 20°C/s, and the decrease rate was 40°C/s. Last minus first rating was calculated as tTS.
2.4 Statistical analysis
Statistical analyses were performed using SPSS (SPSS Inc., Chicago, IL, USA, version 15). The CPM response was calculated as the difference between the pain scores of the two ‘test-stimuli’. A negative value for CPM response represents pain reduction with a more efficient CPM response. Paired t-test was used in order to compare the difference between the ‘test-stimulus’ before and during the ‘conditioning-stimulus’. Since the various CPM paradigms applied in the current study represent diverse physical units (i.e., °C, NPS, kPa), we standardized the response in each of the CPM paradigms into z-scores using the formula: z=(x–μ)/<sigma>, where x was the raw CPM response, μ was the mean of the population and <sigma> was the standard deviation of the population. This procedure allows us to more easily graphically compare differences in individual responses across paradigms. Furthermore, we examined the correlations between the CPM responses obtained by the different protocols, using Spearman’s correlations with the Bonferroni correction for multiple comparisons. Regression analyses were performed for each CPM paradigm inordertoexamine the effects of gender, age, and painfulness of the ‘test-stimulus’ and the ‘conditioning-stimulus’ on the CPM responses. Data are presented as means±standard deviation. Statistical significance was defined as p < 0.05.
3 Results
3.1 Characteristics of the CPM response
Table 2 presents the ‘test-stimuli’ values obtained before and during the ‘conditioning-stimulus’, as well as the pain scores obtained for the ‘conditioning-stimulus’ and the CPM response in physical units for each paradigm. As shown in the table, an efficient CPM was observed for the PPT and tTS modalities, while no significant effect was found for the other modalities in this cohort.
Description of the stimulation scores of the entire sample for each paradigm (mean±SD).
Conditioning (NPS) | ‘Test-stimulus’ before the ‘conditioning-stimulus’ | ‘Test-stimulus’ during the ‘conditioning-stimulus’ | CPM response | p Value[a] | |
---|---|---|---|---|---|
HPT (C°) | 61.8 ± 23.3 | 44.0 ± 3.7 | 44.0 ± 3.4 | –0.10 ± 2.3 | 0.849 |
PPT(kPA) | 67.5 ± 20.4 | 220.2 ± 70.3 | 345.6 ± 90.3 | –125.3 ± 63.9 | 0.000 |
HP (NPS) | 56.9 ± 23.3 | 53.9 ± 15.3 | 56.4 ± 15.8 | 0.83 ± 14.6 | 0.281 |
PP (NPS) | 65.7 ± 18.6 | 61.2 ± 8.9 | 61.2 ± 12.1 | 0.03 ± 12.7 | 0.989 |
tTS (ANPS) | 54.0 ± 23.2 | 26.5 ±21.3 | 17.0 ± 19.6 | –9.54 ± 22.6 | 0.021 |
mTS (ANPS) | 62.0 ± 22.7 | 14.3 ± 15.5 | 9.3 ± 16.2 | –4.98 ± 19.9 | 0.172 |
No role for gender or age was observed in relation to the CPM magnitude in any of the paradigms. A regression model examined the pain 60 intensity and the painfulness of the ‘test-stimulus’ and the ‘conditioning-stimulus’ as predictors for the CPM response. The intensity required to evoke pain 60 (in the HP, tTS and PP paradigms) was not found to predict the CPM response (p = 0.490, p = 0.252, and p = 0.350, respectively). As for the painfulness of the ‘test-stimulus’, higher pain sensitivity was related with higher CPM response in the HPT (p = 0.039), the tTS (p < 0.001), and the mTS (p = 0.002) paradigms, while no such relationship was observed in the PPT, HP or PP paradigms. In addition, the pain levels of the ‘conditioning-stimulus’ did not predict the CPM response in any of the paradigms, and no difference was found between the pain scores of the ‘conditioning-stimuli’ obtained in the different six CPM paradigms [F = 1.77, (df=2, 191), p = 0.121].
3.2 Correlations between CPM responses across paradigms
Not with standing our expectation that the use of a single cohort would result in correlations, at least between some of the test paradigms, no significant correlations were found between any of the CPM responses (Table 3). It should be noted that no significant correlations were found even before correcting for multiple analysis. According to power analysis, however, this correlation would have survived the Bonferroni correction had the sample size been increased to about 100.
Correlations between the six CPM responses (not corrected for multiple comparisons).
PPT | HP | PP | tTS | mTS | |
---|---|---|---|---|---|
HPT | ρ = 0.096 | ρ = 0.340 | ρ = 0.051 | ρ = –0.023 | ρ = 0.081 |
p = 0.607 | p = 0.061 | p = 0.784 | p = 0.901 | p = 0.664 | |
PPT | ρ = 0.000 | ρ = 0.318 | ρ = –0.235 | ρ = 0.217 | |
p = 0.998 | p = 0.081 | p = 0.187 | p = 0.241 | ||
HP | ρ = 0.203 | ρ = 0.227 | ρ = –0.267 | ||
p = 0.272 | p = 0.204 | p = 0.146 | |||
PP | ρ = –0.037 | ρ = 0.074 | |||
p = 0.841 | p = 0.689 | ||||
tTS | ρ = 0.054 | ||||
p = 0.771 |
Given that in the raw data of the PPT paradigm all subjects demonstrated pain inhibition, it was used to better illustrate the pattern of consistency and the intra-individual characteristics of the CPM response across the various paradigms. Each CPM response was transformed into z score and were plotted to examine their distribution pattern. This was done by assigning black and white colors, respectively, to the most and the least efficient CPM responses (see Fig. 1 ). It can clearly be seen in Fig. 1 that individuals do not sustain a certain profile of CPM efficiency, but rather exhibit a more efficient response in some modalities and a less efficient response in others.

Characteristics of the CPM distribution for each paradigm. We assign black and white colors to the most and the least efficient CPM responses, respectively according to the CPM responseinthe PPT paradigm. The rest ofthe CPM responses are coloredingray. For each subjects aninconsistent response pattern of more efficient CPM response in some paradigms and a less efficient in others is observed.
4 Discussion
Despite the growing interest in the clinical relevance of descending inhibition, as tested via CPM, it remains unclear as to which psychophysical test paradigm best reveals the individual profile of pain modulation. The recent reviews by Pud et al. [19] and van Wijk and Veldhuijzen [21] on the various measurements and modalities currently used for this purpose point to the lack of studies employing more than one CPM paradigm in the same cohort. The present study was conducted to expand our knowledge about the response patterns of different CPM paradigms assessed in the same sample of healthy subjects. Since most of the relevant pain patients are older than the standard university student cohorts enrolled for experimental pain studies, and since CPM response decreases with age [22,23], we specifically targeted subjects above age 40.
We tried to decrease the variability by using uniform ‘conditioning-stimuli’ because the effect of the ‘conditioning-stimulus’ on the CPM response has already been demonstrated. Granot et al. [24] showed a positive correlation between the CPM responses induced by two types of ‘conditioning-stimuli’. Two other studies revealed higher CPM responses for the cold pressor test as compared to muscle pain, mechanical pain, or tourniquet pain [25,26]. Furthermore, an animal study showed distinct DNIC responses induced by two different ‘conditioning-stimuli’, namely, electrical and inflammatory. Although both paradigms induced robust DNIC responses, they were distinct in their underlying neurotransmitter-related mechanisms. Specifically, the DNIC induced by the electrical stimulation was blocked by a2-adrenoreceptor antagonist, whereas the DNIC induced by hypertonic saline was reversed by both naloxone and a2-adrenoreceptor antagonist [27].
The findings of these studies indicate that the application of different ‘conditioning-stimuli’ may activate different descending inhibitory pathways influencing the extent of the CPM response. Therefore, we focused on the ‘test-stimuli’ by using a variety of modalities and psychophysical measures and maintaining uniform ‘conditioning-stimuli’. Our findings revealed lack of correlations, as well as considerable variability in CPM response, across the various paradigms under these conditions. Thus, these findings point to the central role of the choice of modality and the type of psychophysical measure of the ‘test-stimulus’ in determining the CPM response.
Methodological characteristics can influence the variability in the CPM responses in several ways. First, different stimulation modalities may activate the peripheral nerve fibers (Aβ, Aδ or C) in a different manner, thereby activating different nociceptive pathways that have varying impacts on the central nervous system [28]. Second, a specific modality might evoke a certain cognitive and/or emotional response, based, for example, on the subject’s past pain experience, which may activate a different facet of inhibition [29]. Finally, some of the inter-modality variability may also be attributed to genetic factors. For example, Diatchenko et al. [30] noted that the COMT polymorphism of met/met homozygotes is associated with greater thermal temporal summation as compared to that of val/val homozygotes. Such an association, however, was not observed in response to pressure or ischemic pain modalities. Thus, the capacity of pain modulation is a multifaceted trait that can be expressed differently in response to the application of different CPM paradigms. As such, it is expected that various CPM test paradigms will provide different levels of sensitivity and specificity in characterizing the endogenous modulation capacity of individual patients, though this outcome cannot be discerned by the current study performed with healthy subjects.
Comparative studies of various ‘test-stimuli’ in the CPM paradigm have been minimally done. Lindstedt et al. [31] examined the CPM response assessed by three types of ‘test-stimuli’: pressure pain threshold, heat pain, and nociceptive flexion reflex. A significant correlation was found between the pressure pain threshold and heat pain CPM responses. However, no correlations were found with the nociceptive flexion reflex CPM response and the aforementioned CPM paradigms. Our results are in partial agreement with this report, and this discrepancy may be attributed to the different methodologies used in CPM assessment. In their study, the ‘conditioning-stimulus’, ischemic pain, lasted for 2 min and during this period, the three ‘test-stimuli’ were delivered in a non-randomized order and with only 1-min interstimulus breaks. Moreover, the CPM for the heat pain was calculated only on the basis of pain ratings reported after 30s [31]. These differences in the observed correlations emphasize the effects of methodological considerations on the CPM response. Since our psychophysical data cannot dissect neuroanatomical structures, we can only assume that the CPM response is not a single, uniform response. Therefore, the relevant recommendation for future studies centered on clinical purposes is to use more than one ‘test-stimulus’.
In our concept, there is a continuous spectrum of the CPM response, between pain inhibition on one end, and pain facilitation on the other. This represents the normal variation among individuals. The technicalities of the various testing paradigms determine the range of results per protocol used. Thus, for some protocols the distribution of results is more in the inhibitory range, while for other protocols, the opposite happens. Therefore, we do not think that an overall inhibitory response is a requisite for a certain protocol to be considered relevant. Rather, it is the clinical application that will eventually direct researchers to prefer the use of a certain paradigm. The protocol used in Yarnitsky et al. [16] consisted of a different, more robust, conditioning stimulus that might have contributed to the more inhibitory response to the paradigm.
The significance of our findings should be considered with an awareness of several study limitations. First, we tested a relatively small sample of subjects due to difficulties in recruiting middle-aged, pain-free healthy subjects. Second, although all subjects were assessed in the same setting, the lack of correlations may have been the result of low session-to-session reliability of CPM responses. Third, inter-examiner variation may have affected the CPM responses, given the administration of the CPM paradigms by three different experimenters. However, it should be noted that all three experimenters were trained by the same person and used the same instructions. Moreover, the tests were randomly administered in order to minimize possible inter-test and inter-experimenter bias [32,33]. Despite the a for ementioned limitations, our results highlight important methodological issues in regard to CPM testing.
5 Conclusions
In the current study variability in the CPM responses was observed. This may suggest that the capacity of pain modulation is a multifaceted trait, whose expression varies with the application of different CPM paradigms. Conclusions about which CPM paradigm better reveals the individual efficacyofendogenous analgesia should be reached according to the relevance of a given paradigm in the clinical setting. The CPM paradigm considered as the most relevant in terms of reflecting endogenous analgesia efficacy maybe the one that can predict a patient’s risk of developing a pain disorder or that can provide greater benefit from a specific pain intervention. However, this understanding has not yet been fully achieved. Until more solid clinically relevant data are available, CPM assessment in the clinical setting should be further investigated via the application of several CPM paradigms using different modalities.
DOI of refers to article: http://dx.doi.org/10.1016/j.sjpain.2012.11.003.
-
Funding: This research was supported by ISF grant 147/08 to MG and DY.
-
Conflict of interest: The authors would like to state that there are no conflicts of interest in relation to this work.
References
[1] LeBars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain 1979;6:283–304.Suche in Google Scholar
[2] Yarnitsky D, Arendt-Nielsen L, Bouhassira D, Edwards RR, Fillingim RB, Granot M, Hansson P, Lautenbacher S, Marchand S, Wilder-Smith O. Recommendations on terminology and practice of psychophysical DNIC testing. Eur J Pain 2010;14:339.Suche in Google Scholar
[3] Bragdon EE, Light KC, Costello NL, Sigurdsson A, Bunting S, Bhalang K, Maixner W. Group differencesin pain modulation: pain-free women compared to pain-free men and to women with TMD. Pain 2002;96:227–37.Suche in Google Scholar
[4] King CD, Wong F, Currie T, Mauderli AP, Fillingim RB, Riley 3rd JL. Deficiency in endogenous modulation of prolonged heat paininpatients with Irritable Bowel Syndrome and Temporomandibular Disorder. Pain 2009;143:172–8.Suche in Google Scholar
[5] Maixner W, Fillingim R, Booker D, Sigurdsson A. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain 1995;63:341–51.Suche in Google Scholar
[6] Maixner W, Fillingim R, Sigurdsson A, Kincaid S, Silva S. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain. Pain 1998;76:71–81.Suche in Google Scholar
[7] Wilder-Smith CH, Robert-Yap J. Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome. World J Gastroenterol 2007;13:3699–704.Suche in Google Scholar
[8] Wilder-Smith CH, Schindler D, Lovblad K, Redmond SM, Nirkko A. Brain functional magnetic resonance imagingofrectal pain and activationof endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut 2004;53:1595–601.Suche in Google Scholar
[9] Kosek E, Hansson P. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 1997;70:41–51.Suche in Google Scholar
[10] Lautenbacher S, Rollman GB. Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 1997;13:189–96.Suche in Google Scholar
[11] Julien N, Goffaux P, Arsenault P, Marchand S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 2005;114:295–302.Suche in Google Scholar
[12] Staud R. Abnormal pain modulation in patients with spatially distributed chronic pain: fibromyalgia. Rheum Dis Clin North Am 2009;35:263–74.Suche in Google Scholar
[13] Staud R, Robinson ME, Vierck Jr CJ, Price DD. Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain 2003;101:167–74.Suche in Google Scholar
[14] Pielsticker A, Haag G, Zaudig M, Lautenbacher S. Impairment of pain inhibition in chronic tension type headache. Pain 2005;118:215–23.Suche in Google Scholar
[15] Edwards RR, Ness TJ, Weigent DA, Fillingim RB. Individual differences in diffuse noxious inhibitory controls (DNIC): association with clinical variables. Pain 2003;106:427–37.Suche in Google Scholar
[16] Yarnitsky D, Crispel Y, Eisenberg E, Granovsky Y, Ben-Nun A, Sprecher E, Best LA, Granot M. Prediction of chronic post-operative pain: pre-operative DNIC testing identifies patients at risk. Pain 2008;138:22–8.Suche in Google Scholar
[17] Wilder-Smith OH, Schreyer T, Scheffer GJ, Arendt-Nielsen L. Patients with chronic pain after abdominal surgery show less preoperative endogenous pain inhibition and more postoperative hyperalgesia: a pilot study. J Pain Palliat Care Pharmacother 2010;24:119–28.Suche in Google Scholar
[18] Yarnitsky D, Granot M, Nahman-Averbuch H, Khamaisi M, Granovsky Y. Conditioned pain modulation (CPM) predicts duloxetine efficacy in painful diabetic neuropathy. Pain 2012;153:1193–8.Suche in Google Scholar
[19] Pud D, Granovsky Y, Yarnitsky D. The methodology of experimentally induced diffuse noxious inhibitory control (DNIC)-like effect in humans. Pain 2009;144:16–9.Suche in Google Scholar
[20] Granot M, Granovsky Y, Sprecher E, Nir RR, Yarnitsky D. Contact heat-evoked temporal summation: tonic versus repetitive-phasic stimulation. Pain 2006;122:295–305.Suche in Google Scholar
[21] van Wijk G, Veldhuijzen DS. Perspective on diffuse noxious inhibitory controls as a model of endogenous pain modulation in clinical pain syndromes. J Pain 2010;11:408–19.Suche in Google Scholar
[22] Edwards RR, Fillingim RB, Ness TJ. Age-related differences in endogenous pain modulation: a comparison of diffuse noxious inhibitory controls in healthy older and younger adults. Pain 2003;101:155–65.Suche in Google Scholar
[23] Riley 3rd JL, King CD, Wong F, Fillingim RB, Mauderli AP. Lack of endogenous modulation and reduced decay of prolonged heat pain in older adults. Pain 2010;150:153–60.Suche in Google Scholar
[24] Granot M, Weissman-Fogel I, Crispel Y, Pud D, Granovsky Y, Sprecher E, Yarnit-sky D. Determinants of endogenous analgesia magnitude in a diffuse noxious inhibitory control (DNIC)paradigm:doconditioning stimulus painfulness, gender and personality variables matter? Pain 2008;136:142–9.Suche in Google Scholar
[25] Oono Y, Nie H, Matos RL, Wang K, Arendt-Nielsen L. The inter- and intra-individual variance in descending pain modulation evoked by different conditioning stimuli in healthy men. Scand J Pain 2011;2:162–9.Suche in Google Scholar
[26] Arendt-Nielsen L, Sluka KA, Nie HL. Experimental muscle pain impairs descending inhibition. Pain 2008;140:465–71.Suche in Google Scholar
[27] Wen YR, Wang CC, Yeh GC, Hsu SF, Huang YJ, Li YL, Sun WZ. DNIC-mediated analgesia produced by a supramaximal electrical or a high-dose formalin conditioning stimulus: roles of opioid and alpha2-adrenergic receptors. J Biomed Sci 2010;17:19.Suche in Google Scholar
[28] Heinricher MM, Tavares I, Leith JL, Lumb BM. Descending control of nociception: specificity, recruitment and plasticity. Brain Res Rev 2009;60:214–25.Suche in Google Scholar
[29] Thompson T, Keogh E, French CC, Davis R. Anxiety sensitivity and pain: generalisability across noxious stimuli. Pain 2008;134:187–96.Suche in Google Scholar
[30] Diatchenko L, Nackley AG, Slade GD, Bhalang K, Belfer I, Max MB, Goldman D, Maixner W. Catechol-O-methyltransferase genepolymorphisms areassociated with multiple pain-evoking stimuli. Pain 2006;125:216–24.Suche in Google Scholar
[31] Lindstedt F, Berrebi J, Greayer E, Lonsdorf TB, Schalling M, Ingvar M, Kosek E. Conditioned pain modulation is associated with common polymorphisms in the serotonin transporter gene. PLoS ONE 2011;6:e18252.Suche in Google Scholar
[32] Kállai I, Barke A, Voss U. The effects of experimenter characteristics on pain reports in women and men. Pain 2004;112:142–7.Suche in Google Scholar
[33] Weisse CS, Foster KK, Fisher EA. The influence of experimenter gender and race on pain reporting: does racial or gender concordance matter? Pain Med 2005;6:80–7.Suche in Google Scholar
© 2012 Scandinavian Association for the Study of Pain
Artikel in diesem Heft
- Editorial comment
- A new treatment principle for neuropathic pain? Approved oncologic drugs: Epidermal growth factor receptor (EGFR) inhibitors dramatically relieve severe neuropathic pain in a case series
- Educational case report
- Epithelial growth factor receptor (EGFR)-inhibition for relief of neuropathic pain–A case series
- Editorial comment
- Conditioned pain modulation (CPM) is not one single phenomenon – Large intra-individual differences depend on test stimulus (TS) and several other independent factors
- Original experimental
- The role of stimulation parameters on the conditioned pain modulation response
- Editorial comment
- Why we are proud to publish well-performed negative clinical studies?
- Clinical pain research
- Evaluation of the analgesic efficacy of AZD1940, a novel cannabinoid agonist, on post-operative pain after lower third molar surgical removal
- Editorial comment
- What really goes on behind closed doors: The need to understand communication about pain
- Observational studies
- The association between physicians’ attitudes to psychosocial aspects of low back pain and reported clinical behaviour: A complex issue
- Editorial comment
- It’s not cool to reduce the skin temperature and activate the TRPM8 ion channel after spinal injury
- Original experimental
- Activation of TRPM8 cold receptor triggers allodynia-like behavior in spinally injured rats
- Editorial comment
- Sunburn—A human inflammatory pain model for primary and secondary hyperalgesia
- Original experimental
- Central origin of pinprick hyperalgesia adjacent to an UV-B induced inflammatory skin pain model in healthy volunteers
- Editorial comment
- Validity of conclusions on treatment efficacy: Difficulties in patient recruitment and a large number of drop-outs may lead to bias
- Original experimental
- The nitric oxide synthase inhibitor and serotonin-receptor agonist NXN-188 during the aura phase of migraine with aura: A randomized, double-blind, placebo-controlled cross-over study
- Correspondence
- Which patients benefit from treatment?
- Correspondence
- Reply to Letter to the Editor
- Acknowledgement of Reviewers
Artikel in diesem Heft
- Editorial comment
- A new treatment principle for neuropathic pain? Approved oncologic drugs: Epidermal growth factor receptor (EGFR) inhibitors dramatically relieve severe neuropathic pain in a case series
- Educational case report
- Epithelial growth factor receptor (EGFR)-inhibition for relief of neuropathic pain–A case series
- Editorial comment
- Conditioned pain modulation (CPM) is not one single phenomenon – Large intra-individual differences depend on test stimulus (TS) and several other independent factors
- Original experimental
- The role of stimulation parameters on the conditioned pain modulation response
- Editorial comment
- Why we are proud to publish well-performed negative clinical studies?
- Clinical pain research
- Evaluation of the analgesic efficacy of AZD1940, a novel cannabinoid agonist, on post-operative pain after lower third molar surgical removal
- Editorial comment
- What really goes on behind closed doors: The need to understand communication about pain
- Observational studies
- The association between physicians’ attitudes to psychosocial aspects of low back pain and reported clinical behaviour: A complex issue
- Editorial comment
- It’s not cool to reduce the skin temperature and activate the TRPM8 ion channel after spinal injury
- Original experimental
- Activation of TRPM8 cold receptor triggers allodynia-like behavior in spinally injured rats
- Editorial comment
- Sunburn—A human inflammatory pain model for primary and secondary hyperalgesia
- Original experimental
- Central origin of pinprick hyperalgesia adjacent to an UV-B induced inflammatory skin pain model in healthy volunteers
- Editorial comment
- Validity of conclusions on treatment efficacy: Difficulties in patient recruitment and a large number of drop-outs may lead to bias
- Original experimental
- The nitric oxide synthase inhibitor and serotonin-receptor agonist NXN-188 during the aura phase of migraine with aura: A randomized, double-blind, placebo-controlled cross-over study
- Correspondence
- Which patients benefit from treatment?
- Correspondence
- Reply to Letter to the Editor
- Acknowledgement of Reviewers